LEQEMBI ® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer's disease (AD). Treatment with LEQEMBI should be initiated in patients with mild ...

Heart disease is once again the leading cause of death in the U.S., according to a new statistical report from the .

We are a reader-supported site and receive compensation from purchases made through these links. See more about our Privacy ...